VolitionRX Ltd [VNRX] stock is trading at $0.49, up 17.13%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The VNRX shares have gain 4.96% over the last week, with a monthly amount glided 2.72%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
VolitionRX Ltd [AMEX: VNRX] stock has seen the most recent analyst activity on April 08, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $2.50. Previously, The Benchmark Company downgraded its rating to Hold on February 01, 2023. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $8 on March 10, 2021. Maxim Group initiated its recommendation with a Buy and recommended $6 as its price target on May 16, 2018. The Benchmark Company reiterated a Buy rating for this stock on May 14, 2018, and downed its price target to $5. In a note dated September 07, 2016, Rodman & Renshaw reiterated an Buy rating on this stock and revised its target price from $12 to $10.
VolitionRX Ltd [VNRX] stock has fluctuated between $0.40 and $0.90 over the past year. VolitionRX Ltd [AMEX: VNRX] shares were valued at $0.49 at the most recent close of the market.
Analyzing the VNRX fundamentals
VolitionRX Ltd [AMEX:VNRX] reported sales of 1.31M for the trailing twelve months, which represents a growth of 43.64%. Gross Profit Margin for this corporation currently stands at 0.32% with Operating Profit Margin at -14.25%, Pretax Profit Margin comes in at -18.5%, and Net Profit Margin reading is -18.36%. To continue investigating profitability, this company’s Return on Assets is posted at -2.82, Equity is 1.08 and Total Capital is -75.48. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4285 points at the first support level, and at 0.3659 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.5451, and for the 2nd resistance point, it is at 0.5991.
Ratios To Look Out For
For context, VolitionRX Ltd’s Current Ratio is 0.40. Also, the Quick Ratio is 0.40, while the Cash Ratio stands at 0.31. Considering the valuation of this stock, the price to sales ratio is 38.62.
Transactions by insiders
Recent insider trading involved Micallef Jacob Vincent, Chief Scientific Officer, that happened on May 19 ’25 when 50000.0 shares were purchased. President and CEO, Reynolds Cameron John completed a deal on May 19 ’25 to buy 20000.0 shares. Meanwhile, President and CEO Reynolds Cameron John bought 0.18 million shares on Mar 26 ’25.
